HM-04

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHM-04
Drug Alias Nameghrelin receptor antagonists (Novo Nordisk)ghrelin receptor antagonists (Helsinn Healthcare)ghrelin receptor antagonists (Helsinn Healthcare)HM-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor antagonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsObesityMetabolic DiseasesPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesHelsinn Healthcare Sa
Inactive CompaniesSapphire Therapeutics IncNovo Nordisk A/S
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsObesityMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A